VMNIX vs. IMMX

In the year-to-date period, VMNIX achieves a 2.02% return, which is significantly higher than IMMX's -5.00% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vanguard Market Neutral Fund Institutional Shares (VMNIX) and Immix Biopharma, Inc. (IMMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VMNIX Sharpe Ratio is 0.31, which is higher than the IMMX Sharpe Ratio of -0.05. The chart below compares the historical Sharpe Ratios of VMNIX and IMMX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

VMNIX's dividend yield for the trailing twelve months is around 5.63%, while IMMX has not paid dividends to shareholders.

The maximum VMNIX drawdown since its inception was -25.35%, smaller than the maximum IMMX drawdown of -88.89%. Use the drawdown chart below to compare losses from any high point for VMNIX and IMMX. For additional features, visit the drawdowns tool.

The current volatility for Vanguard Market Neutral Fund Institutional Shares (VMNIX) is 1.46%, while Immix Biopharma, Inc. (IMMX) has a volatility of 17.94%. This indicates that VMNIX experiences smaller price fluctuations and is considered to be less risky than IMMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.